DRIO vs XBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

DRIO

41.3
AI Score
VS
DRIO Wins

XBIO

36.5
AI Score

Investment Advisor Scores

DRIO

41score
Recommendation
HOLD

XBIO

37score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric DRIO XBIO Winner
Forward P/E 10.5932 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -3.6% 12.0% XBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 41.3/100 36.5/100 DRIO
Profit Margin -169.9% -75.9% XBIO
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL DRIO

Relative Price Performance (Last 90 Days)

DRIO 1M: -7.4% · 3M: -3.8% XBIO 1M: +19.7% · 3M: +31.7%

Current Technical Phase

DRIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.2 · Price: $6.93

XBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.1% over 20 days), RSI 55

RSI (14): 55.3 · Price: $3.95

Fundamentals Snapshot

Metric DRIO XBIO
Market Cap
Forward P/E -5.9 -12.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.6% 1.0%
Operating Margin -1.3% -1.5%
EPS -14.87 -1.15
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DRIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.